These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34065416)
1. Growth Inhibitory Effects of Ester Derivatives of Menahydroquinone-4, the Reduced Form of Vitamin K Yamakawa H; Setoguchi S; Goto S; Watase D; Terada K; Nagata-Akaho N; Toki E; Koga M; Matsunaga K; Karube Y; Takata J Pharmaceutics; 2021 May; 13(5):. PubMed ID: 34065416 [TBL] [Abstract][Full Text] [Related]
2. Prodrugs for Skin Delivery of Menahydroquinone-4, an Active Form of Vitamin K Goto S; Setoguchi S; Yamakawa H; Watase D; Terada K; Matsunaga K; Karube Y; Takata J Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137618 [TBL] [Abstract][Full Text] [Related]
3. Enhanced antitumor effects of novel intracellular delivery of an active form of menaquinone-4, menahydroquinone-4, into hepatocellular carcinoma. Setoguchi S; Watase D; Matsunaga K; Matsubara M; Kubo Y; Kusuda M; Nagata-Akaho N; Enjoji M; Nakashima M; Takeshita M; Karube Y; Takata J Cancer Prev Res (Phila); 2015 Feb; 8(2):129-38. PubMed ID: 25416411 [TBL] [Abstract][Full Text] [Related]
4. Antitumor Effects and Delivery Profiles of Menahydroquinone-4 Prodrugs with Ionic or Nonionic Promoiety to Hepatocellular Carcinoma Cells. Setoguchi S; Watase D; Matsunaga K; Yamakawa H; Goto S; Terada K; Ohe K; Enjoji M; Karube Y; Takata J Molecules; 2018 Jul; 23(7):. PubMed ID: 30013007 [TBL] [Abstract][Full Text] [Related]
5. Vitamin K prodrugs: 2. water-soluble prodrugs of menahydroquinone-4 for systemic site-specific delivery. Takata J; Karube Y; Hanada M; Matsunaga K; Matsushima Y; Sendo T; Oishi R Pharm Res; 1995 Dec; 12(12):1973-9. PubMed ID: 8786976 [TBL] [Abstract][Full Text] [Related]
6. Delivery of the reduced form of vitamin K Toki E; Goto S; Setoguchi S; Terada K; Watase D; Yamakawa H; Yamada A; Koga M; Kubota K; Iwasaki K; Karube Y; Matsunaga K; Takata J Sci Rep; 2022 Nov; 12(1):19878. PubMed ID: 36400879 [TBL] [Abstract][Full Text] [Related]
8. [Drug resistance of acute promyelocytic leukemia (APL) to all-trans retinoic acid (ATRA) and its reversion]. Jiang G; Tang T; Bi K Zhonghua Zhong Liu Za Zhi; 2000 Mar; 22(2):154-7. PubMed ID: 11776647 [TBL] [Abstract][Full Text] [Related]
9. Prodrug for bioreductive activation-independent delivery of menahydroquinone-4: human liver enzymatic activation and its action in warfarin-poisoned human liver. Takata J; Karube Y; Hanada M; Matsunaga K; Iwasaki H Biol Pharm Bull; 1999 Feb; 22(2):172-8. PubMed ID: 10077437 [TBL] [Abstract][Full Text] [Related]
10. Common defects of different retinoic acid resistant promyelocytic leukemia cells are persistent telomerase activity and nuclear body disorganization. Nason-Burchenal K; Maerz W; Albanell J; Allopenna J; Martin P; Moore MA; Dmitrovsky E Differentiation; 1997 Aug; 61(5):321-31. PubMed ID: 9342843 [TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia. Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743 [TBL] [Abstract][Full Text] [Related]
12. all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia. Ozpolat B; Mehta K; Tari AM; Lopez-Berestein G Am J Hematol; 2002 May; 70(1):39-47. PubMed ID: 11994980 [TBL] [Abstract][Full Text] [Related]
13. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Lee KH; Chang MY; Ahn JI; Yu DH; Jung SS; Choi JH; Noh YH; Lee YS; Ahn MJ Biochem Biophys Res Commun; 2002 Sep; 296(5):1125-33. PubMed ID: 12207890 [TBL] [Abstract][Full Text] [Related]
14. Designed ATRA analogue active against ATRA-resistant acute promyelocytic leukemia cells having a single nucleotide substitution in their retinoic acid receptor. Komura N; Ikeda Y; Masuda N; Umezawa Y; Ito K; Kizaki M; Umezawa K Leuk Res; 2007 Mar; 31(3):301-13. PubMed ID: 16968653 [TBL] [Abstract][Full Text] [Related]
15. HA117 endows HL60 cells with a stem-like signature by inhibiting the degradation of DNMT1 via its ability to down-regulate expression of the GGL domain of RGS6. Li S; Jin X; Wu H; Wang Y; Li X; Guo Y; Liang S PLoS One; 2017; 12(6):e0180142. PubMed ID: 28665981 [TBL] [Abstract][Full Text] [Related]